| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/21/1999 | CA2296017A1 Method for producing calcium pyruvates |
| 01/21/1999 | CA2295908A1 New human growth regulator protein |
| 01/21/1999 | CA2295822A1 Novel composition |
| 01/21/1999 | CA2295697A1 Inhibitors of neutrophil mediated oxidant production |
| 01/21/1999 | CA2295666A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy |
| 01/21/1999 | CA2295149A1 Fusion proteins with an immunoglobulin hinge region linker |
| 01/21/1999 | CA2295086A1 Wa545 compositions |
| 01/21/1999 | CA2294732A1 Ctl epitopes from ebv |
| 01/21/1999 | CA2294533A1 6-azauracil derivatives as il-5 inhibitors |
| 01/21/1999 | CA2294244A1 Cyclin dependent kinase inhibiting purine derivatives |
| 01/21/1999 | CA2294145A1 Il-5 inhibiting 6-azauracil derivatives |
| 01/21/1999 | CA2292480A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 01/21/1999 | CA2265671A1 Matrix metalloproteinase inhibitors |
| 01/20/1999 | EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 01/20/1999 | EP0892061A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB |
| 01/20/1999 | EP0892056A2 GidA1 polypeptides from Chlamydia trachomitis |
| 01/20/1999 | EP0892050A2 Human HFIZG53 |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0891985A1 Process for the production of biologically active protein (e.g. TGF) |
| 01/20/1999 | EP0891984A2 Nucleic acid encoding streptococcus pneumoniae response regulator |
| 01/20/1999 | EP0891978A2 5H-Thiazolo (3,2-a) pyrimidine derivatives |
| 01/20/1999 | EP0891778A2 Agents for the prevention and/or treatment of radiation-induced disorders |
| 01/20/1999 | EP0891719A1 Nutritional composition containing methionine |
| 01/20/1999 | EP0891429A2 Recombinant aav vector-based transduction system and use of same |
| 01/20/1999 | EP0891428A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 01/20/1999 | EP0891426A2 Human bikunin |
| 01/20/1999 | EP0891377A1 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 01/20/1999 | EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity |
| 01/20/1999 | EP0891372A1 Growth factor htter36 |
| 01/20/1999 | EP0891365A1 Benzoxazines for enhancing synaptic response |
| 01/20/1999 | EP0891363A1 Heterocyclic compounds and their preparation and use |
| 01/20/1999 | EP0891362A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/20/1999 | EP0891361A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891360A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891358A1 Oxazolidin-2-one derivatives, preparation method therefor and therapeutical use thereof |
| 01/20/1999 | EP0891357A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891356A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891355A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891354A1 N-aminoalkyldibenzofurancarboxamides as dopamine receptor subtype specific ligands |
| 01/20/1999 | EP0891352A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891351A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891350A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891349A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891347A1 Triterpene derivatives with immunosuppressant activity |
| 01/20/1999 | EP0891346A1 Dihydrobenzofuran compounds useful as anti-inflammatory agents |
| 01/20/1999 | EP0891344A1 Alpha 1-adrenergic receptor antagonists |
| 01/20/1999 | EP0891343A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891337A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891333A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891332A1 6-phenylpyridyl-2-amine derivatives |
| 01/20/1999 | EP0891331A1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity |
| 01/20/1999 | EP0891329A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891328A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891322A1 Dimethyl-substituted cyclohexane diene derivatives |
| 01/20/1999 | EP0891189A1 Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 01/20/1999 | EP0891187A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents |
| 01/20/1999 | EP0764149B1 Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same |
| 01/20/1999 | EP0707579B1 Piperidinyl substituted methanoanthracenes as d1/d2-antagonists and 5ht2-serotanin-antagonists |
| 01/20/1999 | EP0693053B1 Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 01/20/1999 | EP0689428B1 Enhanced circulation effector composition and method |
| 01/20/1999 | EP0675714B1 COMBINATION OF A CHOLESTEROL BIOSYNTHESIS INHIBITOR AND A $g(b)-LACTAM CHOLESTEROL ABSORPTION INHIBITOR |
| 01/20/1999 | EP0641327B1 Novel alpha-mannosidase inhibitors |
| 01/20/1999 | EP0630245B1 Protein kinase c inhibitor |
| 01/20/1999 | CN1205702A Pyrido (2,3-b) pyrazine derivatives |
| 01/20/1999 | CN1205699A 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives |
| 01/20/1999 | CN1205695A N-substituted dioxothiazolidylbenzamide derivatives and process for producing same |
| 01/20/1999 | CN1205694A Quinazoline derivatives |
| 01/20/1999 | CN1205339A Total esculentoside and treating application to endometriosis |
| 01/20/1999 | CN1205335A Tricyclic diazepine vasopression antagonists |
| 01/20/1999 | CN1205328A Sulfonylaminocarboxylic acids |
| 01/20/1999 | CN1205224A Clear-heading agent and its prepn. method |
| 01/20/1999 | CN1205212A Fresh preparation of motherwort and its prepn. method |
| 01/19/1999 | US5861512 Reaction of 2-tert-butylcarboxamidepiperazine with acid in solvent, heating, dissolving, cooling, precipitation of crystals |
| 01/19/1999 | US5861510 Antiarthritic agents, antiulcer agents, restenosis, oral diseases |
| 01/19/1999 | US5861496 Nucleic acid and amino acid sequences of a novel squalene epoxidase and to the use of these sequences in the diagnosis, prevention, and treatment of diseases such as hypercholesterolemia and atherosclerosis. |
| 01/19/1999 | US5861484 Treatment of psoriasis, rheumatoid arthritis, hemangiomas, angiofibromas, diabetic retinopathy, neovascular glaucoma,and other vegf-induced pathological angiogenesis and vascular permeability conditions, such as tumor vascularization |
| 01/19/1999 | US5861483 Inhibitor of stem cell proliferation and uses thereof |
| 01/19/1999 | US5861438 Combination therapy to prevent bone loss parathyroid hormone and estrogen agonists |
| 01/19/1999 | US5861436 Inhibitors of the relese of tumor necrosis factor |
| 01/19/1999 | US5861434 Compositions containing L-carnitine or an acyl L-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders and a method for treating cardiovascular disorders |
| 01/19/1999 | US5861428 Alleviation of osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, corneal ulceration, proteinuria, aneurysmal aortic disease, dystrophobic epidermolysis bullosa, inflammation, osteopenias, tempero |
| 01/19/1999 | US5861427 Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitors |
| 01/19/1999 | US5861426 Nitro esters of aromatic compounds with amide or ester groups |
| 01/19/1999 | US5861418 Aminobenzoic acid derivatives |
| 01/19/1999 | US5861404 2,9-disubstituted purin-6-ones |
| 01/19/1999 | US5861402 1,4-dihydropyridine compounds |
| 01/19/1999 | US5861401 Treatment of congestive heart failure |
| 01/19/1999 | US5861396 Purin-6-one derivatives |
| 01/19/1999 | US5861392 Therapeutic heterocycles |
| 01/19/1999 | US5861390 Treatment of breast cancer |
| 01/19/1999 | US5861386 Prevention of loss of bone mass or bone minerals |
| 01/19/1999 | US5861385 Drug intermediates for compounds that lower cholesterol or treat hyperlipoproteinemia formed by reduction of acid or ester compounds with hydroxy or ether groups |
| 01/19/1999 | US5861384 Suppression of rejection after transplants for organs orally in an amount in the range of about 5 to 2000 mg. |
| 01/19/1999 | US5861380 Oxadiazole, thiadiazole and triazole peptoids as inhibitors of human neutrophil elastase; adult respiratory distress syndrome; antiarthritic,-inflammatory,-ischemic,-tumor and -carcinogenic agents and other hne-mediated conditions |
| 01/19/1999 | US5861379 Chimeric fatty body-pro-GRF analogs with increased biological potency |
| 01/19/1999 | US5861377 Antistasin type serine protease inhibitors |
| 01/19/1999 | US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes |
| 01/19/1999 | US5861159 Controlled release of pharmaceutically active substances for immunotherapy |
| 01/19/1999 | CA2179987C Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine |
| 01/19/1999 | CA2121484C Treatment of acne or of pseudofolliculitis barbae |